NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









MPM BioImpact

MPM BioImpact

Boston, Massachusettsmpmbioimpact.com

Overview

MPM BioImpact is a biotechnology investment firm that creates and invests in private and public companies developing transformative therapies and life-saving drugs.

Year Founded

1997

Portfolio Companies

42

Investments

MPM BioImpact investments
CompanyDateStageLead
CrossballMar 2026Series BCo-investor
Crossbow TherapeuticsMar 2026Series BCo-investor
Protego BiopharmaDec 2025Series BCo-investor
Reunion Neuroscience Inc.Sep 2025Series A ExtensionLead
Umoja BiopharmaJan 2025Series C-

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBoston, Massachusetts
Year Founded1997

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.